The study will be part of Verily’s Project Baseline, which aims to study disease testing methods and antibodies. Through the new immune response study, the companies hope to analyze how COVID-19 affects the immune system immediately after someone tests positive for the virus.
The exploratory study will enroll individuals confirmed positive for COVID-19, who will participate from home. Researchers will collect biological measurements, clinical and epidemiological data at the time of COVID-19 testing to identify longitudinal molecular and/or immunological signatures connected with the progression the disease over 28 days.
More articles on health IT:
Wearable devices can identify COVID-19 cases up to 1 week before diagnosis, study finds
Geisinger AI tool increases cardiac death risk prediction accuracy by 13%
Fired Florida health department data scientist drops lawsuit over police raid on her home
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
